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Background: Adenosine-to-inosine (A-to-I) RNA editing is recognized as a cellular mechanism for generating both
RNA and protein diversity. Inosine base pairs with cytidine during reverse transcription and therefore appears as
guanosine during sequencing of cDNA. Current approaches of RNA editing identification largely depend on the
comparison between transcriptomes and genomic DNA (gDNA) sequencing datasets from the same individuals,
and it has been challenging to identify editing candidates from transcriptomes in the absence of gDNA
information.
Results: We have developed a new strategy to accurately predict constitutive RNA editing sites from publicly
available human RNA-seq datasets in the absence of relevant genomic sequences. Our approach establishes new
parameters to increase the ability to map mismatches and to minimize sequencing/mapping errors and unreported
genome variations. We identified 695 novel constitutive A-to-I editing sites that appear in clusters (named “editing
boxes”) in multiple samples and which exhibit spatial and dynamic regulation across human tissues. Some of these
editing boxes are enriched in non-repetitive regions lacking inverted repeat structures and contain an extremely
high conversion frequency of As to Is. We validated a number of editing boxes in multiple human cell lines and
confirmed that ADAR1 is responsible for the observed promiscuous editing events in non-repetitive regions, further
expanding our knowledge of the catalytic substrate of A-to-I RNA editing by ADAR enzymes.
Conclusions: The approach we present here provides a novel way of identifying A-to-I RNA editing events by
analyzing only RNA-seq datasets. This method has allowed us to gain new insights into RNA editing and should
also aid in the identification of more constitutive A-to-I editing sites from additional transcriptomes.
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RNA editing is a post-transcriptional modification process
which not only expands the number of functions encoded
by our genomes but also provides additional mechanisms
of gene regulation. The most predominant form of such
editing in higher eukaryotes is adenosine-to-inosine
(A-to-I) RNA editing, which is catalyzed by members* Correspondence: linglingchen@sibcb.ac.cn; liyang@picb.ac.cn
†Equal contributors
2State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell
Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of
Sciences, Shanghai 200031, China
1Key Laboratory of Computational Biology, CAS-MPG Partner Institute for
Computational Biology, Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences, Shanghai 200031, China
© 2013 Zhu et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orof ADAR enzyme family (adenosine deaminases that act
on RNA) [1,2]. The resulting inosines preferentially base
pair with cytidines (C) and are therefore functionally gua-
nosines (G), although there has been evidence that inosine
can also pair with guanosine [3]. Thus, A-to-I editing can
have profound effects on downstream RNA processing
and function, including recoding of open reading frames,
altering the pattern of alternative splicing, interfering
with microRNA function, modulating RNAi activity, and
playing other roles in gene regulation [1,2].
The pattern of A-to-I RNA editing, either site-specific or
promiscuous, is likely to determine the fate of an edited
RNA molecule. The majority of A-to-I editing in the hu-
man transcriptome is located within inverted-repeated Alu
elements (IRAlus) positioned within introns and UTRs asd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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libraries to genomic sequences [4-7], and by genome-wide
profiling of transcriptomes and genomic DNAs from the
same individuals [8-10]. RNAs with extensively edited
IRAlus within their 3′UTRs are retained in nuclear para-
speckles [11-13], although this retention is not always
complete [12,14]. Compared to promiscuous A-to-I RNA
editing in repetitive elements, site-specific editing in coding
regions provides a rich source of genetic recoding that can
influence protein function. The best-characterized editing
sites in mammals occur in codons of pre-mRNAs encoding
glutamate receptor B (GluR-B) and serotonin receptor 2C
(5-HT2CR) [15,16]. In addition, site-specific A-to-I RNA
editing outside coding sequences has been shown to inter-
fere with miRNA pathways by affecting microprocessor or
Dicer cleavage, RISC loading and mature miRNA function
[17-22]. Thus, it is becoming increasingly apparent that
A-to-I RNA editing plays important roles in regulating
gene expression and product function.
Inosine base pairs with cytidine during reverse transcrip-
tion and therefore appears as G during sequencing of
cDNA. Thus, A-to-I editing sites can be inferred by the
presence of G at a given position in a cDNA sequence but
only A in the corresponding genomic position [1,2]. Most
recently, the application of next-generation sequencing to
cDNAs (RNA-seq) and genomic DNAs from the same hu-
man individual followed by extensive computational ana-
lyses revealed an additional large number of editing sites
in both Alu and non-Alu elements [8-10]. Thus, the emer-
gence of new technologies and approaches has enabled
the identification of a growing list of editing sites.
Transcriptome and genomic DNA sequencing datasets
are not always available for single individuals. However,
RNA-seq data is widespread and available through pub-
lic datasets and thus represents a relevantly rich source
of yet unexplored RNA editing sites. There are two fea-
tures that currently limit the application of RNA-seq
data to identify A-to-I RNA editing without the relevant
genomic information. On one hand, the nature of nu-
cleotide mismatches reduces the ability to uniquely align
RNA-seq reads to the genome, and therefore reduces
the capability to retrieve nucleotide variants. On the
other hand, true editing events are often hidden in a
background noise caused by sequence errors, mapping
errors and genome variations, including genomic single
nucleotide polymorphisms (SNPs) and somatic muta-
tions. Thus, it has been challenging to accurately identify
editing candidates from transcriptomes in the absence of
gDNA information.
To overcome the aforementioned issues, we have devel-
oped a new pipeline to accurately predict editing sites from
18 human RNA-seq datasets, even without knowledge of
relevant genomic sequences from which the RNA-seq
data were derived. We identified 2,245 constitutive A-to-Iediting sites that occur in clusters (named “editing boxes”).
Some of these are enriched in non-repetitive elements and
exhibit an extremely high A-to-I conversion frequency.
Importantly, editing sites located in non-repetitive editing
boxes were validated in multiple human cell lines using
conventional PCR and Sanger sequencing and were
proven to be catalyzed by ADAR1. Finally, distinct editing
ratios of RNA sites in editing boxes from different tissues/
cell lines clearly suggest a spatial and dynamic regulation
of A-to-I RNA editing across human tissues.
Results
A computational flow to predict clustered A-to-I editing
sites from transcriptomes only
It has been challenging to discover A-to-I RNA editing
sites from RNA-seq datasets for a number of reasons.
First, edited As are interpreted as Gs in sequencing
reads. This leads to problems with alignment of edited
reads to the genome. Second, random sequencing errors
and mapping errors are often problematic. Third, some
genomic polymorphisms and somatic mutations are un-
predictable from an individual genome without know-
ledge of the genomic sequence. Finally, transcriptome
and genomic DNA sequencing datasets are not always
available for single individuals. To overcome these diffi-
culties, we have developed a computational approach
consisting of four key steps (Figure 1) to identify RNA
editing from multiple RNA-seq datasets in the absence
of the relevant genomic sequence.
STEP 1: a two-round unique mapping strategy with
Bowtie to improve the mapping ability and to obtain an
increased number of aligned mismatches. Multiple map-
ping pipelines have been developed to align individual
RNA-seq reads to the corresponding genomes [23-26].
However, most mappers with default setting are not suit-
able to deal effectively with mismatches that result from
RNA editing. To increase the mapping sensitivity to cap-
ture more mismatches, we applied a two-round-unique
mapping with Bowtie to analyze 18 human cell line and
tissue transcriptomes (Methods). As we found that both
ends of sequence reads contain higher sequencing errors
(Additional file 1), we trimmed 75-nt reads from both
ends to 70-nt long for the first alignment. This mapping
scheme allowed us to not only keep longer reads to map
repetitive elements in the genome, but also retrieved a
large number of mismatches. For instance, the second
split-alignment resulted in only 1-4% of increased
mapped reads compared with first alignments (Figure 2B,
top panel, Additional file 2); however, the mapped mis-
matches were increased 20%-30% in different samples
(Figure 2B, bottom panel). In addition, the application of
this two-round mapping strategy with other aligners also
dramatically increased the mismatch calling, but with a lit-
tle increase in mapped reads (Additional file 3). Clearly,
Figure 1 A computational approach for the prediction of constitutive A-to-I editing sites in clusters from multiple RNA-seq datasets.
STEP 1: Two-round unique mapping. STEP 2: Removal of sequencing errors and annotated gSNPs. STEP 3: Removal of unannotated gSNPs with
customized PSS. STEP 4: Identification of constitutive A-to-I editing sites clustered in editing boxes. See Materials and Methods for details.
Zhu et al. BMC Genomics 2013, 14:206 Page 3 of 16
http://www.biomedcentral.com/1471-2164/14/206this two-round-unique mapping scheme significantly im-
proved the alignment capability for mismatches, which in
turn allowed us to obtain an accurate dataset of the editing
site/ratio prediction and to identify previously unreported
A-to-I conversions in human transcriptomes.
STEP 2: a series of stringent cutoffs to reduce sequencing/
mapping errors and to remove known genomic SNPs.
As different samples vary in genome coverage and se-
quencing depth, we used the HPB value (Additional file 4)
to normalize the expression level for each transcribed site
across samples, and selected a relatively higher cutoff
at HPB > 5 for a given site, comparable to RPKM/FPKM>
5 for a gene, to call potential editing candidates in
highly expressed sites. In our calculation, 5 HPB represented
8 ~ 19 raw hits for each base in different transcriptomes
(Additional file 5). The relatively high HPB in our ana-
lysis allowed us not only to locate the position of an
editing site, but also to accurately calculate the editing
ratio of each site.
STEP 3: a new parameter, PSS, to remove unreported
genomic variances by taking advantage of large numbers
of RNA-seq datasets. PSSs for known SNPs were calcu-
lated using a similar strategy and their distribution was
then plotted as a control (Figure 3C). From our analysis,30% to 70% of mismatches carrying an overall PSS
from −18 to 0 are known SNPs (black line with dots in
Figure 3C), suggesting that the remaining mismatches car-
rying an overall PSS from −18 to 0 could be unreported
genomic variations. Importantly, 100% (11 of 11) randomly
picked mismatches with a PSS from −18, -16, or −11 were
proven to be true genomic variations, but not editing
events, by Sanger sequencing (Figure 3D and Additional
file 6). On the other hand, only less than 5% of mismatches
carrying an overall PSS from 1 to 18 are known SNPs,
suggesting that we could remove over 95% of reported and
unreported genomic variations with a PSS ≥1 (Figure 3C).
However, given the fact that there are a large amount of
known gSNPs carrying PSS at −2 to 2 (blue histogram in
Figure 3C), in the current analysis, we set up a even more
stringent cutoff to remove potential genomic variation sites
with PSS < 3, which filtered out over 97% expressed SNPs
(red line in Figure 3C). From the data we noted that some
well-characterized editing sites were found in a tissue-
specific manner. For example, Q/R and R/G sites in the
pre-mRNA of GluR-B were detected only in brain with the
expected editing frequencies (Additional file 7A). These
tissue-specific editing events were largely due to the brain-
specific expression of GluR-B RNAs (Additional file 7B). In
Figure 2 A dramatic increase of nucleotide mismatch calling from a two-round unique mapping approach. (A) Multiple mapped reads
from RNA-seq data of human colon tissue were uniquely aligned to chr2: 37,328,032 -37,328,129 of the hg19 genome with the number of
mismatches shown on the right. The predicted editing sites are highlighted with arrows. Reads with 4 and 5 mismatches (bold on right) were
identified with the split and 2nd-round mapping approach and would have been missed with the default mapping. (B) The two-round mapping
approach achieved a significant increase of mapped mismatches (bottom panel) and subtle changes of mapped reads (top panel). The 1st-round
mapping, light grey bars; the split and 2nd-round mapping, dark grey bars.
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tively detected from multiple human tissues (constitu-
tive editing sites), and tissue-specific expressed RNAs
and editing events (tissue/cell-specific editing sites)
were not considered.
STEP 4: predicting constitutive A-to-I editing sites
that occur in clusters. Owing to the absence of relative
genomic sequence information with which to compare
RNA sequence data, we enriched high confidence
A-to-I editing sites by considering the fact that A-to-I
sites could be clustered or promiscuously edited within
specific genomic regions. In our analysis, we found that
many A-to-G/T-to-C sites, but few from other types of
nucleotide conversions or known SNPs, could be clustered
(Table 1B and 1C). In addition, we further performed
strand specific RNA-seq with RNAs collected from H9
cells and found that 100% of the identified T-to-C sites
were transcribed from “-” strand of chromosome and
A-to-G sites were from “+” strand of chromosome in H9
cells, suggesting clustered A-to-G/T-to-C mismatcheswere most likely to be true A-to-I editing. As they were
detected from no less than three transcriptomes, we classi-
fied these A-to-G/T-to-C mismatches after STEP 4 as
constitutive A-to-I sites, and named regions containing
such sites as “editing boxes”.
Since it is known that A-to-I editing sites are
enriched in Alu elements, we calculated the enrichment
of A-to-I conversion in Alu elements after each step of
our computational flow. As shown in Table 1A, ~ 60%
mismatches in Alu elements were A-to-G/T-to-C con-
versions after STEP 2, compared to ~ 24% before STEP
2 (data not shown). Furthermore, ~ 83% mismatches in
Alu elements were A-to-G/T-to-C conversions after
PSS cutoff, indicating PSS could greatly improve the
identification of true editing sites. Finally, 100% mis-
matches identified in Alu elements were A-to-Is after
the cluster filtering, while several regions clustered
with other types of nucleotide conversions failed to be
validated with Sanger sequencing (Table 1B and data
not shown).
Figure 3 Development and application of Potential SNP Scores (PSS) to filter out previously unannotated genome variations. (A) The
distribution of mismatch ratios of all non-gSNPs mismatches and (B) known gSNPs in H9 cells. PSS was given to test the possibility of a mismatch
for either genomic variation (PSS = −1, with mismatch ratio≥ 95% or between 40% ~ 60% in grey shadow) or editing (PSS = +1, with mismatches
ratios between 5% ~ 40% or between 60% ~ 95%) in H9 cells. (C) Application of PSS to filter out previously unannotated genome variations. Over
97% of known genomic SNPs were filtered out with PSS cutoff at 3 (red dashed line). (D) Validation of previously unannotated genome variations
predicted with PSS cutoff. Three examples with Sanger sequencing results were shown with their genomic locations, types of conversion and
PSSs (full validation list is available in Additional file 6).
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sites clustered in 266 editing boxes (Additional file 5).
Although the editing boxes were largely from Alu ele-
ments, we found 7 editing boxes from non-Alu repetitive
regions and 21 editing boxes from non-repetitive regions
(Table 1B). The average length of non-repetitive editing
boxes is 71 nt, which is shorter than that of Alu and
non-Alu repetitive editing boxes (Table 1B). However,
the average A-to-I nucleotide conversion rate in non-
repetitive editing boxes is about 51% of all As, which is
higher than Alu and non-Alu repetitive editing boxes
(Table 1B), suggesting the surprising result that promis-
cuous A-to-I editing can occur in non-repetitive regions.
Characterization of predicted constitutive A-to-I sites in
editing boxes
Unlike tissue-specific editing, all 2,245 A-to-I sites in
editing boxes identified in this study were constitutiveediting sites that existed in multiple tissues/cell lines.
These editing sites are all located in noncoding regions,
with the majority in noncoding exons and intergenic re-
gions and ~10% in introns (Figure 4A). Compared with
several other recent studies [8-10,27] and DARNED
database (Figure 4), 1550 editing sites (69%) were
reported in at least one dataset and 695 (31%) were
novel sites (Figure 4B, left panel). More interestingly,
809 reported editing sites were found in only one of the
six datasets, and only one site was present in all six
datasets (Figure 4B, right panel). The huge difference
among these datasets could be due to a variety of cells/
tissues used in individual studies as well as different
computational approaches in acquiring editing sites.
These comparisons also suggested that our computa-
tional flow allowed us to efficiently predict A-to-I
editing sites across transcriptomes even without the sup-
port of relevant genomic information.
Table 1 Characterization of editing prediction pipeline
A
# of all m.m. in Alu # of A-to-I in Alu A-to-I ration in all m.m.
STEP2: w/o PSS cutoff 95,187 57,502 60.41%
STEP3: PSS cutoff 8,721 7,266 83.32%
STEP4: in editing box 1,995 1,995 100%
B
Alu Non-Alu repetitive Non-repetitive
A-to-I Editing boxes (sites) 238 (1995) 7 (61) 21 (189)
Ave. length (nt) ~108 nt ~86 nt ~71 nt
Ave. conversion rate of As to Is ~31% ~40% ~51%
A-to-C 0 0 2 [14]
T-to-G 0 0 1 [6]
A-to-T 0 0 0
T-to-A 0 0 0
C-to-A 0 1 [6] 1 [5]*
G-to-T 0 0 1 [5]
C-to-G 0 0 0
G-to-C 0 0 1 [5]*
C-to-T 0 0 1 [5]
G-to-A 0 0 1 [6]*
C
in IRAIus within 1 kb to IRAIus > 1 kb to IRAIus
A-to-I editing boxes (sites) 208 (1763) 36 (310) 24 (172)
(A) The enrichment of A-to-I conversion in Alu elements after each step of our computational flow. (B) Editing boxes/sites distribution in Alu, non-Alu repetitive
and non-repetitive regions. Asterisk indicated non A-to-Gs (noncanonical editing) sites are validated to be false positives. (C) Editing boxes/sites distribution in
IRAlus, within 1 kb to IRAlus and over 1 kb to IRAlus.
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editing sites in editing boxes. These new sites are
located in noncoding regions, including noncoding
exons, intergenic regions and introns (Figure 4C). In
addition, many editing sites in intergenic regions were
located within 10 kb of annotated genes, suggesting
these unannotated regions could be extended 3′-UTRs
of adjacent genes. Although editing box sites were
largely from Alu elements, 50 and 116 editing box sites
were from non-Alu repetitive or non-repetitive re-
gions, respectively (Figure 4D). Additional analyses re-
vealed that the majority of these editing boxes were
located in or close to IRAlus (within 1 kb to IRAlus)
(Table 1C), suggesting promiscuous editing in non-Alu
editing boxes could be facilitated by the recruitment of
ADAR enzymes to nearby duplex structures. However,
111 new editing sites in non-repetitive regions (from
172 in total, Table 1C) were further than 1 kb from the
nearest IRAlus (Figure 4E), suggesting that other
mechanisms may be involved in these promiscuous
editing events.Predicted constitutive A-to-I sites from non-repetitive
editing boxes are catalyzed by ADAR1
It is known that the majority of A-to-I editing in
the human transcriptome occurs within Alu elements
[4-6,8-10,27]; however, it was unexpected to identify
promiscuous editing sites in non-repetitive sequences.
Thus, we randomly selected several such editing boxes
for validation.
In an intergenic region between genes CCDC75 and
EIF2AK2 in chromosome 2, two non-repetitive editing
boxes (purple bars in Figure 5A) and one Alu editing
box (one of IRAlus, pink bar in Figure 5A) are sepa-
rated by over 1 kb. We found that this intergenic region
is differentially expressed in all examined cell lines/
tissues (Additional file 8). We further checked epigen-
etic modifications of ChIP-Seq analysis from ENCODE
project, but these showed no signs of active transcrip-
tion starts adjacent to this region, suggesting this
intergenic region is more likely co-expressed with its
neighboring gene(s). More careful analysis revealed
that similar expression signals were detected in the
Figure 4 Characterization of RNA editing sites in editing boxes. (A) The genomic distribution of constitutive A-to-I editing box sites. (B)
Comparison of predicted constitutive editing box sites with other studies [8-10,27] and DARNED database. 695 (about 31%) constitutive editing
sites in clusters were previously unreported, compared with 1550 (69%) sites were overlapped with at least one dataset (left panel). Only a few
sites were reported from multiple datasets (right panel). (C) The genomic distribution of newly identified editing box sites. (E) The distribution of
newly identified editing box sites in IRAlus, within or over 1 kb to IRAlus regions. (D) The distribution of newly identified editing box sites in Alu,
non-Alu repetitive or non-repetitive regions.
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reported (blue bars) poly(A) site in H9 cells, suggesting
this intergenic region is an extended 3′ UTR of
EIF2AK2. This was further confirmed by strand specific
RNA-seq in H9 cells.
The validation results from gDNAs and cDNAs of
both H9 and HeLa cells for the two editing boxes from
non-repetitive regions revealed a high correlation with
our bioinformatic predictions. Sites predicted to be
edited in H9 and/or HeLa cells (Table 2) with over 10%
editing ratios were validated by Sanger sequences
(Figure 5B and Additional file 9A-9C). In addition, the
estimated editing ratios by the two methods correlate
relatively well (r = 0.845), as indicated by Additional
file 9D. Taken together, these results suggested that our
predicted editing sites in editing boxes are highly
confident. Moreover, knockdown of ADAR1 (Figure 5C)
significantly reduced editing ratio of individual A-to-I
sites in editing boxes (Figure 5D and Additional file 10),
suggesting that editing in non-repetitive editing boxes is
catalyzed by ADAR1.
Since the filtering applied in this study achieved high
accuracy (100% validation) in predicting clustered A-to-Iediting sites, we also investigated the performance of this
method on editing sites that are not clustered (Table 3).
However, only about half of randomly selected predicted
sites could be experimentally validated in both H9 and
HeLa cells (7 out of 15, Table 3). This further indicated
that our method is more reliable for prediction of clus-
tered A-to-I editing sites than for non-clustered ones in
the absence of the relevant genomic sequences.
Characterization of promiscuous A-to-I RNA editing from
non-repetitive editing boxes
Since this work is the first demonstration of promiscuous
editing in non-repetitive regions catalyzed by ADAR1
(Table 1 and Figure 5), we further characterized these sites
in greater detail. Although there were no consensus se-
quences in all non-repetitive editing boxes, we found that
ADAR1 preferentially targets adenosines when the 5′
nearest neighbor is A ≈U >C >G (Figure 6A). This is in
the agreement with known neighbor preferences of
ADAR1 enzyme, but is slightly different from recently re-
fined predicting sites of ADAR editing for an ~800 bp
dsRNA (U >A >C >G) [28]. Moreover, structure predic-
tion revealed that some of such editing boxes could
Figure 5 (See legend on next page.)
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Figure 5 Validation of constitutive A-to-I sites in non-repetitive editing boxes. (A) Three editing boxes were identified within an intergenic
region at chromosome 2. A screenshot from the UCSC genome browser for its sequencing signals in H9 cell (dark blue) and HeLa cell (light blue)
with annotated gene models (exons in thick dark blue bars, introns labeled with arrowheads as transcription direction) was shown. CCDC75 is
transcribed from the plus strand while EIF2AK2 is transcribed from the minus strand of chromosome. A new gene model of EIF2AK2 with
extended 30 UTR (red line) is drawn beneath the UCSC genome browser snapshot box. Two editing boxes in non-repetitive regions (purple bars)
are located in the extended 30 UTR region together with another editing box in Alu (pink bar). (B) Validation of constitutive A-to-I editing sites.
Predicted A-to-I editing sites were indicated with underlines (shown as T-to-Cs on plus strand of chr2), and their predicted editing ratios were
shown above each site in the cDNA sequencing chromatograms. Novel editing sites were highlighted with red arrows and their genomic sites
were indicated in the bottom, reported sites were in black. (C) Knocking down of adar1 in HeLa cells with shRNA. Both RT-qPCR (left panel) and
Western blots (right panel) showed a successful ADAR1 knockdown (sh-adar1) compared with a scramble shRNA (sh-ctrl). (D) Newly identified
promiscuous A-to-I editing sites in non-Alu elements are catalyzed by ADAR1.
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quences (Figure 6B), suggesting the promiscuous A-to-I
RNA editing in non-repetitive editing boxes may involve a
mechanism similar to that of IRAlus. However, since over
90% of these editing boxes were located in or close to
IRAlus, we could not exclude the possibility that theirTable 2 Editing ratios of constitutive A-to-I sites at one editin
chr2: 37,328,008 37,328,012 37,328,013 37,328,
H9 9.1% 5.6%
HeLa 11.5% 24.7% 8.5%
Adipose 30.2% 41.5% 20.7%
Adrenal 41.9% 7.5% 32.3% 25.9%
Brain 24.3% 5.6% 42.3% 28.0%
Breast 9.7% 14.2% 15.5%
Colon 19.3% 19.6% 18.1%
Heart 9.1% 18.4%
Kidney 22.4% 6.4% 29.1%
Liver 50.0% 54.2%
Lung 26.4% 7.8% 19.6% 13.7%
Lymph Node 29.8% 14.3%
Ovary 11.2% 40.1% 15.4%
Prostate 27.8% 7.9% 43.4% 30.3%
Skeletal Muscle 33.3%
Testes 19.6% 16.1% 15.5%
Thyroid 13.2% 8.2% 31.8% 20.3%
White Bllod Cell 7.6% 31.1% 24.5%
PSS 13 5 8 13
Darned databasea Yes
Li, et al. 200924 Yes
Bahn, et al. 2012-BC9 Yes
Bahn, et al. 2012-U87MG9
Peng, et al. 20128 Yes
Ramaswami, et al. 201210 Yes
Predicted editing ratios of nine A-to-I sites in editing box at chr2: 37,328,008 -37,32
editing or failure of passing our stringent cutoffs (HPB > 5, etc.). Five annotated site
http://darned.ucc.ie/.editing is coupled to the recruitment of ADAR enzymes
to nearby Alu-related duplex structures [29].
To further test this possibility, we cloned sequences of
editing boxes in 3′UTR of egfp or in the upstream region
of single Alu or IRAlus in 3′UTR of egfp (Figure 6C). We
have previously shown that IRAlus, but not single Alus,g box in 18 human samples
016 37,328,034 37,328,075 37,328,082 37,328,087 37,328,100
43.3% 26.9% 20.0% 8.3%
71.8% 45.8% 18.9% 16.7%
78.0% 74.2% 63.3% 38.1% 8.8%
87.8% 69.5% 53.0% 38.6%
87.2% 63.8% 46.8% 26.6% 14.6%
63.8% 47.0% 50.0% 12.5%
91.8% 50.8% 7.0% 26.9%
53.3% 13.3% 17.6% 18.4%
58.9% 45.9% 15.1% 6.5%
76.0%
59.5% 29.3%
65.7% 39.1% 20.0% 48.6%
71.2% 32.5% 25.8% 23.5%
79.7% 95.6% 46.7% 33.2% 11.4%
20.9%
89.0% 42.6% 38.8% 31.1% 5.5%
64.8% 17.6% 28.8% 32.0%
66.3% 26.3% 36.7%
10 3 5 12 7
Yes Yes Yes
Yes Yes Yes
Yes Yes Yes Yes
Yes Yes
Yes Yes Yes
8,100 are listed in all examined cell lines/tissues. Blank indicates either no
s were reported from different datasets/analyses. aDataset of RNA editing at
Table 3 Comparison of predicted clustered and non-clustered constitutive A-to-I sites
A
A-to-I conversions A-to-Is in H9 and HeLa Numbers of validated sites
Clustered sites 2,245 296 22 of 22
Non-clustered sites 10,220 1,542 7 of 15
B
Predicted A-to-I sites Predicted A-to-I ratios Validation
Chr. location Altered base Gene location H9 HeLa H9 HeLa
chr1:40041484 A- > G (+) Coding 28.1% 29.5% − −
chr4:184186228 A- > G (+) Coding 30.8% 28.1% − −
chr6:159187882 A- > G (+) 30UTR 46.2% 50% − −
chr7:44841489 A- > G (+) 30UTR 78.4% 69.2% + +
chr8:48890109 A- > G (+) 30UTR 29.6% 32.5% + +
chr10:75008955 A- > G (−) 30UTR 59.5% 65.8% + +
chr17:4068050 A- > G (+) 30UTR 31.8% 31.7% − −
chr17:61898921 A- > G (−) Coding 27.5% 16.9% + +
chr17:80445942 A- > G (+) Coding 34.4% 32.1% − −
chr19:10755103 A- > G (−) 30UTR 95.3% 96.7% − −
chr19:34718735 A- > G (+) 30UTR 46.5% 27.9% + +
chr19:39874895 A- > G (+) 30UTR 36.1% 38.9% − −
chr20:30253695 A- > G (+) 30UTR 20.0% 29.9% − −
chrX:54589730 A- > G (+) 30UTR 30.0% 46.3% + +
chrX:54589774 A- > G (+) 30UTR 6.9% 8.8% + +
(A) Comparison of clustered and non-clustered constitutive A-to-I sites identified with or without STEP4 cutoff. Editing sites detected in HeLa and H9 cells were
further used for validation with Sanger sequencing. (B) Validation results of randomly selected non-clustered A-to-I editing sites. “+”, validated to be an editing
site; “-”, validated not to be an editing site.
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vectors, even during transient transfection [12]. We rea-
soned that if the adjacent IRAlus recruit ADARs to the
nearby editing boxes, we would find more editing sites in
editing boxes in vector containing IRAlus than those
containing single Alu or no Alu. Otherwise, if editing
boxes alone are sufficient to recruit ADARs, we would ob-
serve promiscuous editing in all examined vectors. Strik-
ingly, our analyses revealed that sequences in editing
boxes in all examined vectors were extensively edited in a
similar way as that observed in their endogenous loci
(Figure 6C and 6D). These results demonstrated that non-
repetitive editing boxes alone can be edited by ADAR1, in-
dependent of adjacent IRAlus.Constitutive A-to-I sites in editing boxes are highly
dynamic across human tissues
As 2,245 constitutive A-to-I sites could be found in mul-
tiple human tissues and cell lines, we were able to analyze
the spatial and dynamic regulation of A-to-I RNA editing.
Surprisingly, constitutive A-to-I sites in editing boxes arehighly dynamic across human tissues at two levels. On
one hand, individual sites exhibit distinct patterns of
editing across human tissues and cell lines (Table 2 and
Figure 7). On the other hand, the editing efficiency of
closely located editing boxes is highly dynamic. Interest-
ingly, non-repetitive editing boxes (Figure 7, purple histo-
grams, Table 2 and Additional file 11) exhibited even more
striking differences than editing boxes of IRAlus (Figure 7,
pink histograms) among examined samples. This indicated
that different mechanisms could facilitate promiscuous
editing within the same genomic characteristics in differ-
ent tissues/cell lines and that ADAR editing is affected by
more than nearest neighbors and local RNA structures
(Figure 6).
Taken together, we have developed an approach to
quantitatively profile constitutive A-to-I RNA editing
from multiple human transcriptomes in the absence of
the relevant genomic information. The application of
our approach has allowed us to identify a large number
of clustered constitutive A-to-I sites, including 695 novel
sites. Our analysis also revealed that non-repetitive
editing boxes could be promiscuously edited by ADAR1,
Figure 6 Characterization of promiscuous A-to-I RNA editing clustered in non-repetitive editing boxes. (A) Neighbor preferences of A-to-I
RNA editing clustered in non-repetitive or non-Alu repetitive editing boxes. Site “0” indicates the editing sites. Probabilities of two upstream and
two downstream nucleotides are indicated. (B) Structure prediction suggests a dsRNA duplex of two editing boxes in chr2. Genomic locations of
two adjacent editing boxes are highlighted by different colors. (C) Editing of editing boxes is independent of adjacent IRAlus. Sequences with
editing boxes were cloned into 30UTR of egfp mRNA with a pair of adjacent IRAlus (pEGFP-2 EB-IRAlus), a single Alu (pEGFP-2 EB-Alu) or non-Alu
(pEGFP-2 EB). (D) Editing levels in IRAlus, single Alu and editing boxes of each transfected plasmid shown in (C). “+++”, extensive editing; “-”, low
editing; “N.A.”, not detected.
Zhu et al. BMC Genomics 2013, 14:206 Page 11 of 16
http://www.biomedcentral.com/1471-2164/14/206independent of their adjacent IRAlus. Finally, although
functionally unknown, marked differences of editing ra-
tios in the same sites identified in editing boxes clearly
suggest a spatial and dynamic regulation of A-to-I RNA
editing across human tissues.Discussion
RNA-seq datasets, widespread through currently available
public databases, are rich sources to search for A-to-I
RNA editing sites. However, RNA-DNA mismatches
between RNA-seq reads and the genome make the
Figure 7 Highly dynamic regulation of A-to-I editing in editing boxes across human tissues/cell lines. Editing ratios of two non-repetitive
(purple) and one Alu (pink) editing boxes (shown in Figure 5A) were marked with colored histograms for each site in H9 cell, HeLa cell, Adipose
and Brain. The colored dots represent no report of editing events due to the stringent cutoffs. Full dataset for these editing boxes were available
in Additional file 11.
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lematic. In addition, transcriptome and genomic DNA
sequencing datasets are not always available for single in-
dividuals, thus making straightforward prediction of A-to-I
editing sites from available transcriptomes even more
challenging. In this study, we developed a new compu-
tational approach to predict RNA editing from multiple
tissues in the absence of the genome information. An
additional 695 novel A-to-I editing sites have been identi-
fied compared to several other recent studies [8-10,27]
and DARNED database (Figure 4B). We expect to detect
more constitutive A-to-I RNA editing sites with additional
sets of human transcriptomes as inputs by obtaining
a higher PSS value for each A-to-G mismatch site. In
addition, discrepancies of reported editing sites could be
due to a variety of cell lines/tissues used in different studies
(Figure 4B) [8-10,27].
Very recently, Ramaswami et al. also reported the iden-
tification of edited sites from transcriptome data only [30].
Their method was reported earlier [10] and slightly modi-
fied for identifying RNA editing sites in the absence of the
related genomic DNA sequencing datasets [30]. In our
present study, the pipeline was designed to identify clus-
tered and constitutively edited A-to-Is. In total, 2,245 such
editing sites were identified, including 695 new ones.
Strikingly, these new sites were still largely missed byRamaswami et al. [30] although much larger datasets were
used. For example, they identified 181 out of 695 from 40
human lymphoblastoid cell lines, 273 out of 695 from 50
human brain samples, and 339 out of 695 from the same
16 human tissue samples.
Since we focused on clustered A-to-Is which are
constitutive edited in at least three human tissues/
transcriptomes, limited editing sites were identified in
this study. It is also noteworthy that some limitations
exist in this approach, including the insufficiency to pre-
dict more restricted tissue-specific editing, the inad-
equacy to identify some true editing sites with 40-60%
or >95% editing ratios, and inaccuracies in identifying
non-clustered editing sites (about 47% experimental val-
idation, Table 3). For instance, true editing sites, such as
A-to-I sites in pre-mRNAs of GluR-B, were not
addressed in our study. In addition, true editing sites
with low expression or low editing ratios could have
been missed due to stringent cutoffs in the computa-
tional flow. These true editing sites would be captured if
multiple RNA-seq datasets from the same tissue (to
achieve a higher PSS value) and higher depths of RNA-
seq datasets from individual samples were included in the
future analysis. While a few non A-to-Gs (noncanonical
editing) sites might be expected, none could be vali-
dated as true editing sites. These noncanonical sites
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highly similar genomic duplicate region, as suggested by
Piskol et al. [31]. In the future, more stringent filters are
needed for RNA editing prediction to remove this type
of mapping errors.
Strikingly, we found that promiscuous RNA editing is
not restricted to transcribed inversely orientated repeti-
tive elements, such as IRAlus. Our analysis revealed
many predicted constitutive A-to-I editing sites that
appeared in clusters and were enriched in non-repetitive
editing boxes with an extremely high A-to-I conversion
frequency (Table 1B). A recent study suggested that
editing of non-Alu sites appeared to be dependent on
nearby edited Alu sites, likely by the recruitment of
ADAR enzymes to nearby duplex structures [10]. How-
ever, we demonstrated that editing boxes alone were suffi-
cient to be edited promiscuously by ADAR1 in expression
vectors, and adjacent IRAlus have little effect to facilitate
more editing (Figure 6). Although we could identify no
consensus sequences in non-repetitive editing boxes, they
are likely to form dsRNAs and the edited sites have similar
5′ neighbor preferences as reported recently for other
ADAR1 substrates [28]. Thus, these new substrates pre-
dicted in this study further expanded our knowledge of
the catalytic pattern of A-to-I RNA editing by ADAR1.
Methods
RNA-seq datasets
RNA-seq datasets from 16 human tissues sequenced by
Illumina HiSeq 2000 (Illumina Human Body Map 2.0 Pro-
ject) and two additional cell lines sequenced by Illumina
Genome Analyzer IIx (GAIIx) [32] were retrieved from
Gene Expression Omnibus (GEO:GSE30611 for tissues
and GEO:GSE24399 for cell lines). About 40 ~ 80 million
75-nt single reads from each poly(A) + RNA-seq sample
were obtained and further trimmed to 70-nt long at both
5′ and 3′ ends for 2 nt and 3 nt, respectively to reduce
high sequencing errors at read ends (Additional file 1).
Customized mapping strategy (STEP 1)
A two-round-unique mapping strategy with Bowtie [23],
SOAP [8], or BWA [9] was applied to retrieve an in-
creased number of mismatch calling (Figure 1). First
Bowtie (v 0.12.8) mapping was performed from 70-bp
reads to the hg19 human genome/junction [32] with up
to three mismatches. After removal of multiple-aligned
reads, unmapped 70-bp reads were split into two 35-nt
fragments. 35-nt fragments from 5′ and 3′ were sequen-
tially applied for the second unique mapping with up to
three mismatches. The mapped 35-nt fragments were
then extended to the other half with no more than 6
mismatches in total. In addition, reads with a distribu-
tion bias of mismatches that indicate higher sequencing
errors at read ends are also excluded in this analysis.Other aligners (like BWA) can certainly be used for
analysis directly with high mismatch allowance, but
new parameters are needed to avoid/remove sequen-
cing and mapping errors. The split scheme allowed us
to retrieve more mismatches (up to six editing sites
within 70-nt compared with three in default), and im-
proved our capability in identifying the clustered RNA
editing sites (Figure 2).
Removal of sequencing errors and annotated gSNPs
(STEP 2)
As the strand information of these RNA-seq datasets
was not available, we referred plus strand of (“+”) chro-
mosomes as reference for mismatch calling. In addition
to trim 75-nt reads from both ends to 70-nt, we carried
out the following stringent criteria for mismatch calling:
(i): Each mismatch site must have a Hits Per Billion-
mapped-bases (HPB) > 5. Since multiple RNA-seq datasets
with different sequencing depths were used in this study,
we developed HPB to normalize the expression level
for each base across samples, and selected a HPB
> 5 for each mismatch site (comparable to RPKM/FPKM
> 5 for genes, Additional file 4) to focus on highly
expressed mismatches. (ii): To improve the predicted
editing accuracy and reduce false positives, we used mis-
match ratio > 5% as a cutoff. Mismatch ratios were calcu-
lated by using mismatched hits vs all hits on the same
sites. For example, G:(A + C +G+T +N) > 5% for A-to-G
mismatch in a corresponding genomic position as A, and
etc. (iii): To reduce random sequencing errors and to im-
prove the correct assignment of sequence reads, we used
effective signal > 95% as a cutoff. For example G:(C +G +
T +N) > 95% for A-to-G mismatch, and etc. (iv): Require at
least two individual reads with the same type of nucleotide
conversion. (v): We finally filtered out gSNPs from the com-
mon SNP database (build 135, http://hgdownload.cse.ucsc.
edu/goldenPath/hg19/database/snp135Common.txt.gz) and
1000 Genome database (http://evs.gs.washington.edu/
EVS/, downloaded on July 15, 2012).
Removal of unannotated gSNPs by customized PSS (STEP 3)
PSS was set up to further reduce unknown genomic noise
by taking advantage of multiple human tissue RNA-seq
datasets. Notably, most mismatches showed low ratios
(< 20%) from multiple human tissues, while some showed
high mismatch ratios (>60%) (Figure 3A, and Additional
file 12). In contrast, mismatch ratios of known gSNPs were
significantly enriched in two peaks: one major peak at
around 100% (homozygous) and a minor peak at around
50% (heterozygous) mismatch ratio (Figure 3B, Additional
file 12). Theoretically, genomic variations would give rise
to either ~ 50% or ~ 100% mismatch ratios depending on
whether the variation is heterozygous (Additional file 6A)
or homozygous (Additional file 6B) [33]. For a given
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was given to test its probability for either a genome vari-
ation (PSS = −1, with mismatch ratio ≥ 95% or between
40% ~ 60%) or an editing (PSS = 1, with mismatches ratios
between 5% ~ 40% or between 60% ~ 95%) in each sample
(Figure 3A and Additional file 12). To optimize parame-
ters for PSS cutoff by considering both efficiency of gSNPs
removal and the number of nucleotide variants remained
after the removal, we permuted all possible combinations
among 40% ~ 60% and 90% ~ 100%. The combination of
40% ~ 60% and ≥ 95% in current analysis is among the best
parameter for our purpose (Zhu, et al., unpublished data).
A final overall PSS for each mismatch site was obtained by
adding up PSSs from multiple tissues and cell lines. PSSs
for known SNPs were calculated with a similar strategy and
their distribution was then plotted against PSS from −18 to
18. With cutoff at PES < 3, over 97.5% expressed SNPs were
filtered out.
Identification of constitutive A-to-I sites in editing box
regions (STEP 4)
Mismatch sites were selected using the following cri-
teria: (i) predicted editing sites were constitutively tran-
scribed at least from three human tissues/cell lines; (ii)
each site is no longer than 50 bp away from the nearest
site and the minimum transcribed genomic region is
20 bp long; (iii) Each site has a greater than 20% mis-
match rate in at least one tissue; (iv) at least 5 mis-
match sites clustered in one region with at least 20%
conversion rate for each type of nucleotide. Thus, We
named these regions containing promiscuous edited A-
to-I sites as “editing boxes”.
Characterization of constitutive A-to-I sites in editing
boxes
Previously identified editing sites were retrieved from the
RNA editing database (http://darned.ucc.ie/) and different
studies [8-10,27] for comparison. RefSeq Genes and anno-
tated intron/exon boundaries were retrieved from from
UCSC (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/
database/refFlat.txt.gz). Alu and non-Alu repetitive ele-
ments were retrieved from http://hgdownload.cse.ucsc.
edu/goldenPath/hg19/database/rmsk.txt.gz. IRAlus were
defined as any two or more inversely oriented Alu ele-
ments located within two kilobases in their genomic loca-
tion [6,12,34].
Analyses of neighbor preferences and RNA secondary
structure
Neighbor preferences were calculated based on predicted
constitutive editing sites in non-repetitive or non-Alu re-
petitive regions, by extending 2 bases in both upstream
and downstream flanking regions. The neighbor prefer-
ences were drawn by software WebLogo [35]. Thestructure of adjacent two editing boxes at chr2 was pre-
dicted by RNAfold from ViennaRNA Package 2.0.7 [36].
Cell culture, plasmid construction and transfection,
knockdown of ADAR1, and Western blots
HeLa cells were cultured using standard protocol pro-
vided by ATCC. Human embryonic stem cells (H9 line)
were maintained as described before [37]. Sequences of
editing box region (Additional file 13) were cloned into
the pEGFP series vectors [12] and each plasmid was
transfected into HeLa cells for 24 hours prior to harvest
total RNAs for editing analysis. Sense and antisense oli-
gonucleotides were designed based on a human ADAR1
targeting sequence (5′- GTTGACTAAGTCACATGT
AAA-3′) [38] and a control scramble sequence (5′-
GATGGCATTACGGCATGTTCA-3′) [39] and cloned
into pLVTHM vector. Lentivirus particles were pro-
duced in HEK-293FT cells with the co-transfection of
packaging vectors psPAX2 and pMD2.G. For infection,
HeLa cells were incubated with concentrated viral parti-
cles at 37°C overnight and the medium was changed to
fresh the next day. Infected HeLa cells were collected
72 hours later for Western blots with goat anti-ADAR1
(Santa Cruz Biotechnology).
Total RNA isolation, RT-PCR, and Sanger sequencing
validation
Total RNAs from HeLa, ADAR1 knockdown HeLa cells,
transfected HeLa cells, and H9 cells were extracted with
Trizol Reagent (Invitrogen) according to the manufac-
turer’s protocol. After treatment with DNase I (Ambion,
DNA-free™ kit), the cDNA was transcribed with Super-
Script II (Invitrogen) with oligo (dT) or random hexamer.
Genomic DNAs were purified from both cell lines by
TIANamp Genomic DNA kit (Tiangen Biotech). PCR
products from cDNAs and gDNAs were amplified with
primers (Additional file 13), and predicted A-to-I editing
sites were validated in available cell lines with the conven-
tional Sanger sequencing. Editing ratios of validated A-to-I
sites by Sanger sequencing were calculated by “ImageJ”
(http://rsb.info.nih.gov/ij/index.html). Briefly, the areas of
edited and unedited signals, indicated as the signal inten-
sities at each site, were carefully selected and measured by
“ImageJ”. The editing ratio was then calculated by dividing
edited intensity with total intensity at the same site.
Correlation of editing ratios calculated from Sanger sequen-
cing and RNA-seq were determined by scatter plot.
Stranded RNA-seq analysis
Strand-specific RNA-seq libraries were prepared with
prereleased Directional mRNA-seq Library Kits (Illumina)
with minor modifications. Briefly, after enriched by oligo-
dT selection, poly(A) + RNAs were fragmented, and
treated with phosphatase and polynucleotide kinase to
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the 3′ and 5′ ends of RNA fragments and reverse tran-
scribed using a primer complementary to the 3′ linker.
cDNA library was then amplified and sequenced on
HiSeq2000 with 1x100 bp reads. The sequence file can be
accessed from the NCBI Sequence Read Archive by GEO
Accession Number GSE44450.
Conclusions
We present an integrative approach to quantitatively
profile constitutive A-to-I RNA editing from multiple
human transcriptomes in the absence of the relevant
genomic information. The application of our approach
has allowed us to identify a large number of clustered
constitutive A-to-I sites, including 695 novel ones. We
further demonstrated that non-repetitive editing boxes
could be promiscuously edited by ADAR1, independent
of their adjacent IRAlus. Strikingly, clear differences of
editing levels in the same editing box sites but from dif-
ferent tissues/cell-lines were also observed, strongly indi-
cating a spatial and dynamic regulation of A-to-I RNA
editing across human tissues. Our work thus offers new
insights into the catalytic pattern and complex regula-
tion of A-to-I editing by ADAR1.
Additional files
Additional file 1: Distribution of RNA-DNA mismatch ratios along
the reads. Reads from 18 of human tissues/cell lines were uniquely
mapped to human reference and all types of RNA-DNA mismatches were
examined at each position of 75-bp reads. Each sample was shown with
different color.
Additional file 2: Numbers of total reads used for alignment,
mapped reads after the first- and second-round alignment for all
transcriptomes from 18 tissues/cell lines.
Additional file 3: The evaluation of the two-round mapping with
other aligners, SOAP [8] (A) and BWA [9] (B). The two-round mapping
approach achieved a significant increase of mapped mismatches (bottom
panel) and subtle changes of mapped reads (top panel). The 1st-round
mapping, light grey bars; the 2nd-round mapping, dark grey bars.
Additional file 4: A formula to show that normalized expression
level (hits per-billion-mapped bases, HPB) of a give site is
equivalent to the value of RPKM/FPKM at one nucleotide base
resolution.
Additional file 5: Constitutive A-to-I editing sites in editing boxes
(see spreadsheet). 2,245 constitutive A-to-I editing sites in editing boxes
were listed with their genomic location, expression levels in each tissue/
cell line (> 5 HPB), unique hits, editing ratios and final PSSs. Each site was
also characterized with information of the overlapped gene, strand
information, overlapping with RepeatMask sequences, genomic location
with IRAlus and comparison with other reported editing datasets
([8-10,27] and DARNED database).
Additional file 6: Validation of unannotated genome variations
filtered out with custom PSS cutoff. Sanger sequencing of gDNAs and
cDNAs from H9 cells were compared from randomly selected (A)
heterozygous or (B) homozygous sites, which were highlighted with
arrows and were proven to be real genome variations. The reference
genome sequences from hg19 human genome are listed with the
variation sites underlined. (C) Additional eight examples of unannotated
SNPs predicted with PSS were shown with genomic locations, types ofnucleotide conversion, and PSS. All of them were validated by Sanger
sequencing. Three heterozygous sites (A) were only in genome 1000
dataset, but not in UCSC SNP135. All other 11 homozygous site (B and C)
were not reported by either dataset.
Additional file 7: Tissue-specific expression of GluR-B in brain.
(A) The well characterized A-to-I editing sites at chr4:158,281,294 and
chr4:158,257,875 in the pre-mRNA of GluR-B were only detected in brain,
with editing frequencies at 69.1% and 91.7%, respectively, as predicted
with our computational flow. (B) The expression of GluR-B in all
examined samples was retrieved from UCSC genome browser and the
relative expression was listed with a normalized FPKM value for each
sample. Note that GluR-B is highly expressed in human tissue but few if
any in other samples.
Additional file 8: Expression of an intergenic region with two
predicted editing boxes in all 18 samples. The expression of the
intergenic region from chr2 along with its adjacent genes in all examined
RNA-seq samples. The gene models, reported and predicted poly(A) sites,
transcription level, and ENCODE epigenetic modifications of ChIP-seq
data (H3K4Me3, H3K4Me1, H3K27Ac) were retrieved from UCSC genome
browser. A new gene model of EIF2AK2 with extended 3′ UTR (red line)
was drawn beneath the UCSC genome browser snapshot. Three editing
boxes (two non-repetitive boxes in purple and one Alu box in pink) were
indicated in the extended 3′UTR region of EIF2AK2. Note that editing
boxes in this unannotated region were highly expressed in all examined
samples.
Additional file 9: Validation of predicted A-to-I editing sites in
other editing boxes. Predicted A-to-I editing sites were highlighted in
red (novel sites) or black (reported ones). Predicted editing ratios were
shown above each site in the cDNA sequencing chromatograms.
Validation of some A-to-I editing sites from editing boxes at (A) chr2:
37,327,644-37,327,685; (B) chr12: 69,237,506-69,237,558; (C) chr14:
23,441,376-23,441,503. Editing ratios in chr12: 69,237,529 (B) were
underestimated in our analysis compared with conventional Sanger
sequencing, probably due to more mismatches in short fragments failed
to map to reference genome. Note that predicted sites with low editing
ratio were difficult to be validated due to the limited sensitivity of the
Sanger method. (D) Scatter plot of editing ratios for 31 A-to-I editing
events (Figure 5B and Additional file 9A-9C) identified by RNA-seq and
Sanger sequencing method. Data points corresponding to false positive
or false negative predictions were shown with red dots. R, R squares and
P value for the linear regression (black line) indicated the relatively good
correlation between these two methods.
Additional file 10: Validations of A-to-I sites in editing boxes with
knockdown of adar1 in HeLa cells. Editing sites in regions
chr2:37,327,656-37,327,685 (A) and chr12: 69,237,509-69,237,534 (B).
Additional file 11: Editing ratios in three editing boxes in
chromosome 2 across human tissues/cell lines.
Additional file 12: The distribution of mismatch ratios of known
genomic SNPs and predicted mismatches in all 18 samples.
Additional file 13: Primer sets for PCR/RT-PCR, editing box cloning
and Sanger sequencing validation. Same primer sets were used for
genomic DNA and cDNA amplification unless addressed separately
(−g for genomic DNA or -c for cDNA). Forward primers were chosen for
Sanger sequencing. Primers for editing box cloning at ch2:37327479–
37328193 region were also listed.
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